Huntington Disease Health Index accurate for patient-reported changes in symptom burden
CHICAGO – The Huntington Disease Health Index was an accurate, clinically meaningful tool for participants in the KINECT-HD trial to report symptomatic disease burden changes when treated with valbenazine, according to a recent study.“The Huntington Disease Health Index is a disease-specific, patient-reported outcome measure [that] was designed to measure clinically meaningful changes
United States Acceleraton Pharma Nancy Hemphill Neurocrine Biosciences Byrobert Herpen Regeneron Pharmaceuticals
Source: healio.com